» Articles » PMID: 37502017

Choline and Contribution to Normal Liver Function of the Foetus and Exclusively Breastfed Infants: Evaluation of a Health Claim Pursuant to Article 14 of Regulation (EC) No 1924/2006

Abstract

Following an application from Procter & Gamble BV pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Belgium, the Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to choline and contribution to normal liver function of the foetus and exclusively breastfed infant. The scope of the application was proposed to fall under a health claim referring to children's development and health. The Panel considers that choline is sufficiently characterised. The claimed effect proposed by the applicant is contribution 'to normal foetal and infant development, especially liver'. The proposed target population is 'unborn fetuses and breastfed infants'. Choline is involved in the structure of cell membranes, cell signalling, metabolism and transport of lipids and cholesterol and neurotransmitter synthesis. Although choline can be synthesised de novo by the human body, depletion-repletion studies in humans show that low choline intake leads to liver dysfunction and muscle damage, which are reverted by the administration of dietary choline. For these functions, de novo synthesis of choline by the human body is insufficient and choline must be obtained from dietary sources. No human studies have addressed the effect of low maternal dietary choline intake on liver function in the fetus or exclusively breastfed infants. However, the Panel considers that the biological role of choline in normal liver function and dietary choline being essential for the function applies to all ages, including fetus and infants. The Panel concludes that a cause and effect relationship has been established between the intake of choline by pregnant and lactating women and contribution to normal liver function of the fetus and exclusively breastfed infants.

Citing Articles

International expert consensus on micronutrient supplement use during the early life course.

Cetin I, Devlieger R, Isolauri E, Obeid R, Parisi F, Pilz S BMC Pregnancy Childbirth. 2025; 25(1):44.

PMID: 39833730 PMC: 11744953. DOI: 10.1186/s12884-024-07123-5.


Evidence and Perspectives for Choline Supplementation during Parenteral Nutrition-A Narrative Review.

Bernhard W, Bockmann K, Minarski M, Wiechers C, Busch A, Bach D Nutrients. 2024; 16(12).

PMID: 38931230 PMC: 11206924. DOI: 10.3390/nu16121873.


Choline-An Underappreciated Component of a Mother-to-Be's Diet.

Dymek A, Oleksy L, Stolarczyk A, Bartosiewicz A Nutrients. 2024; 16(11).

PMID: 38892700 PMC: 11174651. DOI: 10.3390/nu16111767.


A Narrative Review on Maternal Choline Intake and Liver Function of the Fetus and the Infant; Implications for Research, Policy, and Practice.

Obeid R, Schon C, Derbyshire E, Jiang X, Mellott T, Blusztajn J Nutrients. 2024; 16(2).

PMID: 38257153 PMC: 10820518. DOI: 10.3390/nu16020260.


Advancing nutrition science to meet evolving global health needs.

Neufeld L, Ho E, Obeid R, Tzoulis C, Green M, Huber L Eur J Nutr. 2023; 62(Suppl 1):1-16.

PMID: 38015211 PMC: 10684707. DOI: 10.1007/s00394-023-03276-9.


References
1.
Hagstrom H, Hoijer J, Ludvigsson J, Bottai M, Ekbom A, Hultcrantz R . Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease. Liver Int. 2015; 36(2):268-74. DOI: 10.1111/liv.12902. View

2.
Fischer L, daCosta K, Kwock L, Stewart P, Lu T, Stabler S . Sex and menopausal status influence human dietary requirements for the nutrient choline. Am J Clin Nutr. 2007; 85(5):1275-85. PMC: 2435503. DOI: 10.1093/ajcn/85.5.1275. View

3.
Ueland P . Choline and betaine in health and disease. J Inherit Metab Dis. 2010; 34(1):3-15. DOI: 10.1007/s10545-010-9088-4. View

4.
Turck D, Bohn T, Castenmiller J, de Henauw S, Hirsch-Ernst K, Knutsen H . Choline and contribution to normal liver function of the foetus and exclusively breastfed infants: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA J. 2023; 21(7):e08115. PMC: 10369243. DOI: 10.2903/j.efsa.2023.8115. View

5.
. General scientific guidance for stakeholders on health claim applications (Revision 1). EFSA J. 2021; 19(3):e06553. PMC: 7996104. DOI: 10.2903/j.efsa.2021.6553. View